These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15541282)

  • 1. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
    Wei X; Swanson SJ; Gupta S
    J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of anti-erythropoietin antibodies in human serum and plasma: part II. Validation of a semi-quantitative 3H-thymidine uptake assay for neutralizing antibodies.
    Kelley M; Cooper C; Matticoli A; Greway A
    J Immunol Methods; 2005 May; 300(1-2):179-91. PubMed ID: 15927197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to confirm the presence of anti-erythropoietin neutralizing antibodies in human serum.
    Sanchez S; Barger T; Zhou L; Hale M; Mytych D; Gupta S; Swanson SJ; Civoli F
    J Pharm Biomed Anal; 2011 Jul; 55(5):1265-74. PubMed ID: 21497040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum.
    Wei X; Grill DS; Heatherington AC; Swanson SJ; Gupta S
    J Pharm Biomed Anal; 2007 Jan; 43(2):666-76. PubMed ID: 16971087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line.
    Ferguson J; Bird C; Wadhwa M; Burns C
    J Immunol Methods; 2013 Jan; 387(1-2):191-8. PubMed ID: 23142458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
    Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
    J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
    Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
    J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible role of soluble erythropoietin receptors in renal anemia].
    Sakaguchi M; Maeda Y; Naiki Y; Hasegawa H; Kanamaru A
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):524-9. PubMed ID: 12476588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
    McCutcheon KM; Quarmby V; Song A
    J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum.
    Hu J; Gupta S; Swanson SJ; Zhuang Y
    J Immunol Methods; 2009 Jun; 345(1-2):70-9. PubMed ID: 19375427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human sera.
    Shin SK; Ha SK; Lee KW; Yoo TH; Yun SR; Yoon SH; Kim SJ; Lee SK; Heo TH
    J Pharm Biomed Anal; 2010 Jun; 52(2):289-93. PubMed ID: 20133098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly specific and highly sensitive enzyme immunoassays for antibodies to human interleukin 3 (IL-3) and human erythropoietin (EPO) in serum.
    Pauly JU; Harthus HP; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):112-25. PubMed ID: 1801687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
    Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
    J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin.
    Swanson SJ; Ferbas J; Mayeux P; Casadevall N
    Nephron Clin Pract; 2004; 96(3):c88-95. PubMed ID: 15056991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893.
    Baltrukonis DJ; Finco-Kent D; Kawabata TT; Poirier M; Lesauteur L
    J Immunotoxicol; 2006 Sep; 3(3):157-64. PubMed ID: 18958696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive human cell line based bioassay for megakaryocyte growth and development factor or thrombopoietin.
    Page LA; Thorpe R; Mire-Sluis AR
    Cytokine; 1996 Jan; 8(1):66-9. PubMed ID: 8742068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
    Chen XC; Zhou L; Gupta S; Civoli F
    J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
    Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
    J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The preparation and identification of anti-erythropoietin monoclonal antibodies].
    Jiang M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):138-42. PubMed ID: 8242822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.